Transfer to AIM
10 Julio 2003 - 10:33AM
UK Regulatory
RNS Number:4189N
CeNeS Pharmaceuticals PLC
10 July 2003
CeNeS Pharmaceuticals Plc
Transfer to the Alternative Investment Market ("AIM")
As previously indicated on 2 July 2003, the Board of CeNeS Pharmaceuticals Plc
("CeNeS" or the "Company") announces that it intends to apply to the UK Listing
Authority ("UKLA") for the cancellation of its listing of the entire issued
ordinary share capital from the Official List of the UKLA ("Official List") and
to apply to the London Stock Exchange for admission to trading on AIM. It is
anticipated that dealings will commence in the Company's shares on AIM on 8
August 2003 and that the Company's listing on the Official List will be
cancelled on the same day.
The Directors of CeNeS believe that it is more appropriate and cost efficient
for the Company's shares to be traded on the AIM market as it is less regulated
than the Official List.
10 July 2003
Enquiries:
CeNeS Pharmaceuticals Plc 01223 266 466
Neil Clark
Evolution Beeson Gregory 020 7488 4040
Matt Wood
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEBLFFXDBLBBK